Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.

MLA

Nerlakanti, Niveditha, et al. “Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.” Molecular Cancer Therapeutics, vol. 17, no. 12, Dec. 2018, pp. 2796–810. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-18-0602.

APA

Nerlakanti, N., Yao, J., Nguyen, D. T., Patel, A. K., Eroshkin, A. M., Lawrence, H. R., Ayaz, M., Kuenzi, B. M., Agarwal, N., Chen, Y., Gunawan, S., Karim, R. M., Berndt, N., Puskas, J., Magliocco, A. M., Coppola, D., Dhillon, J., Zhang, J., Shymalagovindarajan, S., … Mahajan, K. (2018). Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics, 17(12), 2796–2810. https://doi.org/10.1158/1535-7163.MCT-18-0602

Chicago

Nerlakanti, Niveditha, Jiqiang Yao, Duy T Nguyen, Ami K Patel, Alexey M Eroshkin, Harshani R Lawrence, Muhammad Ayaz, et al. 2018. “Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.” Molecular Cancer Therapeutics 17 (12): 2796–2810. doi:10.1158/1535-7163.MCT-18-0602.